Mission

You probably don’t have to look far to know someone who has been diagnosed with cancer. Every second child born today will be diagnosed with the disease sometime during their lifetime and 7 million Americans will die from it this year. At Protox, our hard work and dedication is driven by the belief that behind every statistic is a life and behind every estimate, hope. Our mission is to change these statistics for the better as we focus on developing and commercializing engineered protein toxins for the treatment of cancer and other proliferative diseases.

What's New

December 28, 2011
Protox Therapeutics Announces Closing of Additional CDN $8.3M Investment By Warburg Pincus

December 23, 2011
Protox Therapeutics Announces Additional CDN $8.3M Investment by Warburg Pincus

December 22, 2011
Protox Completes Dosing of Second Cohort of Patients in Transrectal Study

 

 

 

Events

November 17, 2010
- 11:15 am ET
Protox Presents at Dundee Emerging Growth Conference

 

Stock Quote

LAST TRADE:$0.35
TRADE TIME:3:49PM EST
CHANGE:$0.02 (6.06%)
PREV CLOSE: $0.33
OPEN:$0.335
BID:$0.34
ASK:$0.35